The abstract is read at the publisher; the summary is JClub's.
Angiography-derived vessel fractional flow reserve (vFFR)–guided revascularization is noninferior to wire-based pressure FFR for intermediate coronary stenoses at 1 year, with MACE 3.0% vs 4.1%.
- Why it matters: Wire-based physiological assessment is recommended but underused, and prior randomized vFFR-versus-FFR comparisons have been inconsistent. This trial tests whether vFFR guidance can match wire-based outcomes in intermediate lesions.
- What they did: In a multicenter randomized LIPSIA-STRATEGY trial at 8 German centers, 1,053 patients with acute or chronic coronary syndromes and at least one intermediate stenosis were assigned 1:1 to vFFR- or FFR-guided revascularization. Major adverse cardiac events were assessed at 1 year using a modified intention-to-treat noninferiority test with a 3.5 percentage-point margin.
- The result: At 1 year, MACE occurred in 15/493 (3.0%) with vFFR and 20/493 (4.1%) with FFR (risk difference -1.01 percentage points; upper 97.5% CI 1.29, below margin; P for noninferiority <0.001). Post hoc sensitivity using a relative margin of 1.44 did not meet noninferiority in the primary modified intention-to-treat population, though it did in the post hoc per-protocol analysis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.